DNA Sequencing
Definition
DNA sequencing is a method used to determine the precise order of the four nucleotide bases – adenine, guanine, cytosine and thymine - that make up a strand of DNA. These bases provide the underlying genetic basis (the genotype) for telling a cell what to do, where to go and what kind of cell to become (the phenotype). Nucleotides are not the only determinants of phenotypes, but are essential to their formation. Each individual and organism has a specific nucleotide base sequence.
The two scientists in the photograph are reading the genetic code for a DNA sample on a highlighted light board. Such analysis is usually done by a computer. Credit: National Cancer Institute.

Connections Werner Arber | Exhibition: Fred Sanger
Importance
DNA sequencing played a pivotal role in mapping out the human genome, completed in 2003, and is an essential tool for many basic and applied research applications today. It has for example provided an important tool for determining the thousands of nucleotide variations associated with specific genetic diseases, like Huntington's, which may help to better understand these diseases and advance treatment.
DNA sequencing also underpins pharmacogenomics. This is a relatively new field which is leading the way to more personalised medicine. Pharmacogenomics looks at how a person's individual genome variations affect their response to a drug. Such data is being used to determine which drug gives the best outcome in particular patients. Over 140 drugs approved by the FDA now include pharmacogenomic information in their labelling. Such labelling is not only important in terms of matching patients to their most appropriate drug, but also for working out what their drug dose should be and their level of risk in terms of adverse events. Individual genetic profiling is already being used routinely to prescribe therapies for patients with HIV, breast cancer, lymphoblastic leukaemia and colon cancer and in the future will be used to tailor treatments for cardiovascular disease, cancer, asthma, Alzheimer's disease and depression. Drug developers are also using pharmacogenomic data to design drugs which can be targeted at subgroups of patients with specific genetic profiles.
Discovery
Although scientists established DNA had a double helix structure in 1953, it was to be many more years before they could analyse DNA fragments. In part this reflected the fact that small DNA molecules contain several thousands of nucleotides and it was difficult to obtain large quantities of homogeneous DNA. Scientists also lacked the means to degrade DNA which they needed for sequence analysis.
A new chapter opened up in the 1960s with the emergence of techniques to sequence ribonucleic acid (RNA)s. Ray Wu, a Chinese American biologist based at Cornell University, published one of the first methods for sequencing DNA in 1970. Using highly labelled deoxynucleotides (single units of DNA) and DNA polymerase he found a way to sequence the terminal region of a DNA molecule. Critically, Wu's approach broke the DNA sequence down into several different components for analysis, thereby circumventing the need for large quantities of homogeneous DNA. Subsequently, in 1971, Wu demonstrated his method could sequence the ends of DNA in lambda phage, and two years later that it had the capacity to determine the sequence of any DNA.
Over the course of the 1970s Wu's method was modified by Fred Sanger at the Laboratory of Molecular Biology in Cambridge, UK. In 1975 Sanger, together with Alan Coulson, published what became known as the 'Plus and Minus' technique. This enabled the sequencing of up to 80 nucleotides in one go. Three years later, in 1977, Sanger and his colleagues announced another technique called the 'Sanger method' or 'dideoxy sequencing'. This made it possible to sequence much longer stretches of DNA very rapidly. Their approach appeared alongside the reporting of another technique by Allan Maxam and Walter Gilbert at Harvard University.
While the Maxam-Gilbert method initially proved the most popular, it soon fell out of favour because it necessitated the use of hazardous chemicals and radioisotopes. Added to this, the method it was difficult to scale-up and could not be used in standard molecular biology kits because of its technical complexity. By contrast, the Sanger method gained popularity because it was easier to use and more reliable. It was also amenable to automation, paving the way to the first generation of automated DNA sequencers. The first automated DNA sequencer was devised in 1986 by Leroy Hood and colleagues at the California Institute of Technology together with a team including Lloyd Smith and Michael and Tim Hunkapiller. These machines used capillary electrophoresis rather than gel electrophoresis using slabs.
Several new DNA sequencing methods and machines have been developed since the 1990s. These were built following the introduction of microfluidic separation devices which improved sample injection and speeded up separation times. Such innovations improved both the efficiency and accuracy of sequencing, allowing for high-throughput sequencing, and radically lowered the cost. Between 2001 and 2011 the cost of sequencing a genome shrank from $100 million to $10,000.
Application
DNA sequencing provides the means to know how nucleotide bases are arranged in a piece of DNA. Several methods have been developed for this process. These have four key steps. In the first instance DNA is removed from the cell. This can be done either mechanically or chemically. The second phase involves breaking up the DNA and inserting its pieces into vectors, cells that indefinitely self-replicate, for cloning. In the third phase the DNA clones are placed with a dye-labelled primer (a short stretch of DNA that promotes replication) into a thermal cycler, a machine which automatically raises and lowers the temperature to catalyse replication. The final phase consists of electrophoresis, whereby the DNA segments are placed in a gel and subjected to an electrical current which moves them. Originally the gel was placed on a slab, but today it is inserted into a very thin glass tube known as a capillary. When subjected to an electrical current the smaller nucleotides in the DNA move faster than the larger ones. Electrophoresis thus helps sort out the DNA fragments by their size. The different nucleotide bases in the DNA fragments are identified by their dyes which are activated when they pass through a laser beam. All the information is fed into a computer and the DNA sequence displayed on a screen for analysis.
The method developed by Sanger was pivotal to the international Human Genome Project. Costing over US$3 billion and taking 13 years to complete, this project provided the first complete Human DNA sequence in 2003. Data from the project provided the first means to map out the genetic mutations that underlie specific genetic diseases. It also opened up a path to more personalised medicine, enabling scientists to examine the extent to which a patient's response to a drug is determined by their genetic profile. The genetic profile of a patient's tumour, for example, can now be used to work out what is the most effective treatment for an individual. It is also hoped that in the future that knowing the sequence of a person’s genome will help work out a person's predisposition to certain diseases, such as heart disease, cancer and type II diabetes, which could pave the way to better preventative care.
Data from the the Human Genome Project has also helped fuel the development of gene therapy, a type of treatment designed to replace defective genes in certain genetic disorders. In addition, it has provided a means to design drugs that can target specific genes that cause disease.
Beyond medicine, DNA sequencing is now used for genetic testing for paternity and other family relationships. It also helps identify crime suspects and victims involved in catastrophes. The technique is also vital to detecting bacteria and other organisms that may pollute air, water, soil and food. In addition the method is important to the study of the evolution of different population groups and their migratory patterns as well as determining pedigree for seed or livestock.
DNA Sequencing: timeline of key events
Date | Event | People | Places |
---|---|---|---|
13 Aug 1918 | Frederick Sanger, twice Nobel Prize winner, born | Sanger | Laboratory of Molecular Biology |
14 Aug 1928 | Ray Wu was born in Beijing, China | Wu | Cornell University |
3 Jun 1929 | Werner Arber was born in Granichen, Switzerland | Arber | University of Geneva |
23 Jan 1930 | Beverly Griffin was born in Delhi, Louisiana, USA | Griffin | Imperial College |
23 Aug 1931 | Hamilton O Smith was born in New York City, USA | Smith | Johns Hopkins University, Celera |
1932 | Sanger attends Bryanston School, Dorset, as boarder | Sanger | |
21 Mar 1932 | Walter Gilbert was born in Boston MA, USA | Gilbert | Harvard University, Biogen |
1936 - 1940 | Sanger takes degree in Natural Sciences at Cambridge University | Sanger | Cambridge University |
1940 - 1943 | Sanger studies for a doctorate at Cambridge University | Sanger | Cambridge University |
27 Mar 1942 | John E Sulston born in Cambridge, UK | Sulston | Laboratory of Molecular Biology |
1944 | Sanger starts working on amino acid composition of insulin | Sanger | Cambridge University |
14 Oct 1946 | J Craig Venter was born in Salt Lake City, Utah | Venter | Salt Lake City, Utah |
1952 | First observation of the modification of viruses by bacteria | Luria, Human | University of Illinois |
1955 | Sanger completes the full sequence of amino acids in insulin | Sanger | Cambridge University |
1957 | Victor Ingram breaks the genetic code behind sickle-cell anaemia using Sanger's sequencing technique | Ingram, Sanger | Cambridge University |
1958 | Sanger awarded his first Nobel Prize in Chemistry | Sanger | Cambridge University |
1960 | National Biomedical Research Foundation established | Ledley | Georgetown University |
1960 | Sanger begins to devise ways to sequence nucleic acids, starting with RNA | Sanger | Cambridge University |
1962 | Sanger moves to the newly created Laboratory of Molecular Biology in Cambridge | Sanger | Laboratory of Molecular Biololgy |
23 Jan 1962 | Idea of restriction and modification enzymes born | Arber, Dussoix | University of Geneva |
1965 | Transfer RNA is the first nucleic acid molecule to be sequenced | Holley | Cornell University |
1965 | First comprehensive protein sequence and structure computer data published as 'Atlas of Protein Sequence and Structure' | Dayhoff, Ledley, Eck | National Biomedical Research Foundation, Georgetown University |
1965 | Ledley publishes Uses of Computers in Biology and Medicine | Ledley | National Biomedical Research Foundation |
1965 | Sanger and colleagues publish two-dimension partition sequencing method | Sanger, Brownlee, Barrell | Laboratory of Molecular Biology |
1 Oct 1965 | Werner Arber predicted restriction enzymes could be used as a labortory tool to cleave DNA | Arber | University of Geneva |
1967 | First automatic protein sequencer developed | Edman, Begg | St Vincent's School of Medical Research |
1968 | The first partial sequence of a viral DNA is reported | Wu, Kaiser | Cornell University, Stanford University Medical School |
1969 | First principles for PCR published | Khorana, Kleppe | University of Wisconsin-Madison |
1969 | New species of bacterium is isolated from hot spring in Yellowstone National Park by Thomas Brock | Brock | Case Western Reserve University |
July 1970 | First restriction enzyme isolated and characterised | Smith, Wilcox | Johns Hopkins University |
1971 | Process called repair replication for synthesising short DNA duplexes and single-stranded DNA by polymerases is published | Khorana, Kleppe | MIT |
May 1971 | Complete sequence of bacteriophage lambda DNA reported | Wu, Taylor | Cornell University |
December 1971 | First experiments published demonstrating the use of restriction enzymes to cut DNA | Danna, Nathans | Johns Hopkins University |
1973 | The sequencing of 24 basepairs is reported | Gilbert, Maxam | Harvard University |
1975 | Sanger and Coulson publish their plus minus method for DNA sequencing | Sanger, Coulson | Laboratory of Molecular Biology |
1977 | Complete sequence of bacteriophage phi X174 DNA determined | Sanger | Laboratory of Molecular Biology |
1977 | First computer programme written to help with the compilation and analysis of DNA sequence data | McCallum | Laboratory of Molecular Biology |
February 1977 | Two different DNA sequencing methods published that allow for the rapid sequencing of long stretches of DNA | Sanger, Maxam, Gilbert | Harvard University, Laboratory of Molecular Biology |
October 1978 | Nobel Prize given in recognition of discovery of restriction enzymes and their application to the problems of molecular genetics | Arber, Nathans, Smith | Johns Hopkins University, University of Geneva |
1980 | Sanger awarded his second Nobel Prize in Chemistry | Sanger, Gilbert | Harvard University, Laboratory of Molecular Biology |
January 1980 | European Molecular Biology Laboratory convenes meeting on Computing and DNA Sequences | EMBL | |
1980 | Polyoma virus DNA sequenced | Griffin, Soeda, Arrand, Walsh | Imperial Cancer Research Fund Laboratories |
15 Sep 1980 | Largest nucleic acid sequence database in the world made available free over telephone network | Dayhoff | National Biomedical Research Foundation, Georgetown University |
1982 | Whole genome sequencing method is introduced for DNA sequencing | ||
June 1982 | NIH agrees to provide US$3.2 million over 5 years to establish and maintain a nucleic sequence database | ||
1983 | Sanger retires | Sanger | Laboratory of Molecular Biology |
1983 | Polymerase chain reaction (PCR) starts to be developed as a technique to amplify DNA | Mullis | Cetus Corporation |
June 1984 | Results from PCR experiments start being reported | Mullis | Cetus Corporation |
10 Sep 1984 | First genetic fingerprint revealed | Jeffreys | University of Leicester |
March 1985 | Mullis and Cetus Corporation filed patent for the PCR technique | Mullis | Cetus Corporation |
7 Mar 1985 | DNA fingerprinting principle laid out | Jeffreys | University of Leicester |
17 May 1985 | 1st legal case resolved using DNA fingerprinting | Jeffreys | University of Leicester |
20 Dec 1985 | The Polymerase Chain Reaction (PCR) technique was published | Mullis | Cetus Corporation |
1986 | First machine developed for automating DNA sequencing | Hood, Smith, Hunkapiller | California Institute of Technology, Applied Biosystems |
30 Apr 1986 | Plans for sequencing human genome first laid out | Gilbert, Watson, Berg | |
1988 | US Congress funds genome sequencing | ||
April 1988 | Development of first rapid search computer programme to identify genes in a new sequence | Pearson, Lipman | |
25 May 1989 | David Deamer draws the first sketch to use a biological pore to sequence DNA | ||
1 Feb 1990 | First pitch for US Human Genome Project | ||
1 Oct 1990 | Human Genome Project formally launched | ||
December 1990 | BRCA1, a single gene on chromosome 17, shown to be responsible for many breast and ovarian cancers | King, Lee, Newman, Morrow, Anderson, Huey | University of California Berkeley |
21 Dec 1990 | BRCA1 gene linked with inherited predisposition to cancer | King | University of California Berkley |
1992 | GenBank is integrated into the NIH National Center for Biotechnology Information | ||
1992 | Genetically engineered alpha-haemolysin pore shown to have potential as a biosensor | Bayley, Krishnasastry, Walker, Kasianowicz | Worcester Foundation for Experimental Biology, National Institute of Standards and Technology |
1 Mar 1992 | Method devised to isolate methylated cytosine residues in individual DNA strands providing avenue to undertake DNA methylation genomic sequencing | ||
December 1992 | First experiments show potential of alpha-haemolysin pore for nanopore sequencing | Deamer, Kasianowicz | National Institute of Standards and Technology |
17 Mar 1995 | First patent filed for nanopore sequencing | Church, Deamer, Branton, Balderelli, Kasianowicz | Harvard University, University of California, National Institute of Standards and Technology |
28 Jul 1995 | First complete genome sequence published for a self-replicating free-living organism | Venter, Fleischmann, Adams, White, Clayton, Kirkness, Bult, Tomb, Dougherty, Merrick | The Institute for Genomic Research, Johns Hopkins |
1996 | Complete genome sequence of the first eukaryotic organism, the yeast S. cerevisiae, is published | ||
1996 | Pyrosequencing is introduced for DNA sequencing | Ronaghi, Nyren | Royal Institute of Technology |
November 1996 | First paper published highlighting the potential of nanopore sequencing | Branton, Brandin, Deamer, Kasianowicz | Harvard University, University of California Santa Cruz, National Institute of Science and Technology |
May 1998 | Commercial Human Genome Project launched | Venter | Celera Genomics |
11 Jun 1998 | Complete genome sequence of bacteria that causes tuberculosis published | Cole, Brosch, Parkhill, Garnier, Churcher, Harris, Gordon | Wellcome Trust Sanger Institute, National Institutes of Health, Technical University of Denmark |
17 Jul 1998 | Genome map published for Treponema pallidum, bacteria that causes syphilis | Fraser, Norris, Weinstock, White, Sutton | Institute for Genomic Research, University of Texas Health Centre |
18 Aug 1998 | First patent granted for nanopore sequencing (US patent 5,795,782 ) | Church, Deamer, Branton, Balderelli, Kasianowicz | Harvard University, University of California, National Institute of Standards and Technology |
11 Dec 1998 | Publication of complete genome sequence of the nematode worm Caenorhabditis elegans | Sanger Institute, Washington University | |
1999 | First human chromosome sequence published | ||
December 1999 | Term 'nanopore' used for first time in a publication | Akeson, Branton, Kasianowicz, Brandin, Deamer | Harvard University, University of California Santa Cruz, National Institute of Science and Technology |
2000 | Complete sequences of the genomes of the fruit fly Drosophila and the first plant, Arabidopsis, are published | ||
26 Jun 2000 | Human genome draft sequence announced | ||
14 Dec 2000 | First complete plant genome sequenced | ||
February 2001 | First consensus sequence of human genome published | Sanger, Arber, Wu | Laboratory of Molecular Biology, Celera, Sanger Institute |
March 2001 | Paper published demonstrating possibility of using ion channel to identify individual DNA hairpin molecules | Vercoutere, Winters-Hilt, Deamer, Haussler, Akeson | University of California Santa Cruz |
1 Jul 2001 | Individual DNA strands, up to 30 nucleotides in length, identified using an engineered nanopore | Howorka, Cheley, Bayley | Texas A&M University |
2002 | Complete genome sequence of the first mammalian model organism, the mouse, is published | ||
12 Jul 2002 | Polio: First ever virus synthesised from chemicals alone | Cello, Paul, Wimmer | Stony Brook University |
3 Oct 2002 | Genomic sequence of the principal malaria parasite and vector completed | Celera Genomics, TIGR, Sanger Centre | |
April 2003 | The sequence of the first human genome was published | ||
23 Dec 2004 | FDA approved first DNA microarray diagnostic device | Roche | |
2005 | Oxford Nanopore Technology formally registered as a company | Bayley, Sabnghera, Willcocks | Oxford University |
December 2005 | Oxford Nanopore Technology secured two rounds of seed funding from IP Group Plc | Oxford Nanopore Technology | |
12 Jan 2006 | First time four bases of DNA shown to be easily identified using engineered alpha-haemoplysin pore with a molecular adaptor | Astler, Braha, Bayley | Oxford University |
May 2006 | Last human chromosome is sequenced | ||
June 2006 | Oxford Nanopore Technology raises £7.7 million from various sources allowing it to expand its team | Oxford Nanopore Technology | |
2007 - 2016 | Human Microbiome Project (HMP) carried out | ||
May 2007 | Oxford Nanopore Technology decides to focus its resources on developing nanopore sequencing for DNA sequencing | Oxford Nanopore Technology | |
2008 - 2012 | METAgenomics of the Human Intestinal Tract (MetaHIT) project carried out | ||
10 Feb 2008 | Ray Wu died in Ithaca, USA | Wu | Cornell University |
January 2011 | DNA sequencing proves useful to documenting the rapid evolution of Streptococcus pneumococci in response to the application of vaccines | Wellcome Trust Sanger Institute | |
March 2011 | Hand-held DNA sequencer (MinION) successfully used to sequence first piece of DNA | Clive Brown | Oxford Nanopore Technology |
15 Feb 2012 - 18 Feb 2012 | MinION presented in public for first time | Clive Brown | Oxford Nanopore Technology |
June 2012 | DNA sequencing helps identify the source of an MRSA outbreak in a neornatal intensive care unit | Peacock, Parkhill | Cambridge University, Wellcome Trust Sanger Institute |
December 2012 | DNA sequencing utilised for identifying neurological disease conditions different from those given in the original diagnosis | University of California San Diego | |
19 Nov 2013 | Fred Sanger, the inventor of DNA sequencing, died at the age of 95 | Sanger | Cambridge |
April 2014 | Oxford Nanopore Technology released its palm-sized DNA sequencer to researchers through its MinION Access Programme | Oxford Nanopore Technology | |
11 Jun 2014 | Nick Loman successfully used MinION to sequence the genome of the bacterium Pseudomonas aeruginosa | Loman | University of Birmingham |
April 2015 - Oct 2015 | MinION successfully used to sequence 142 Ebola virus samples in Guinea to help combat outbreak of the disease | Loman, Quick | University of Birmingham |
1 Jun 2016 | Mobile laboratory equipped MinIONS used to sequence and prevent spread of Zika virus in Brazil | Quick, de Jesus, Faria, Loman, Goodfellow, Ramabut | Instituto Evandro Chagas, FIOCRUZ Bahia, ARTIC Network, Oxford Nanopore Technology |
13 Jun 2016 | Beverly Griffin died | Griffin | Imperial College |
3 Nov 2017 | Research showed simple blood test can identify patients at most risk of skin cancer returning | Lee, Gremel, Marshall, Myers, Fisher, Dunn, Dhomen, Corrie, Middleton, Lorigan, Marais | University of Manchester |
15 Nov 2017 | Rare mutation of gene called Serpine 1 discovered to protect against biological ageing process | Khan, Shah, Klyachko, Baldridge, Eren, Place, Aviv, Puterman, Lloyd-Jones, Heiman, Miyata, Gupta, Shapiro, Vaughan | Northwestern University, University of British Columbia, New Jersey Medical School, Tohoku University, |
29 Jan 2018 | MinION shown to be promising tool for sequencing human genome | Loman, Quick, Jain, Koren, Miga, Rand, Sasani, Tyson, Beggs, Dilthey, Fiddes, Malla, Marriot, Nieto, O'Grady, Olsen, Pedersen, Rhie, Richardson, Quinlan, Snutch, Tee, Paten, Philippy, Simpson, Loose | University of Birmingham, University of Nottingham, University of Utah, University of British Columbia, University of East Anglia, Ontario Institute for Cancer Research, University of California Santa Cruz, National Human Genome Research Institute |
9 Mar 2018 | John E Sulson died | Sulston | Laboratory of Molecular Biology, Sanger Institute |
12 Jul 2018 | Genetic test shown to accurately predict which women benefit from chemotherapy | Sparano | Genomic Health |
5 Dec 2018 | Genomics England completed sequencing 100,000 whole genomes | Caulfield | Sanger Institute, Illumina |
January 2019 | High throughput nanopore sequencing device (PromethION 48) launched to support population genomics for human sequencing or plant genomics | Oxford Nanopore Technology | |
March 2019 | ClearLabs launches Food Safety testing using nanopore sequencing | Oxford Nanopore Technology, ClearLabs | |
October 2019 | NHS introduced new fast-track DNA test to scan for rare diseases in babies and children | South West Genomic Laboratory Hub | |
December 2019 | Oxford Nanopore Technology's sequencing technology chosen for a population genome genomics programme for the first time (Abu Dhabi Genome Programme) | Oxford Nanopore Technology | |
January 2020 | Nanopore sequencers begin to be used with ARCTIC protocol to decode the SARS-Cov2 to help combat COVID-19 pandemic | Loman | Oxford Nanopore Technology, ARTIC Network |
10 Jun 2020 | Oxford Nanopore Technology launched its first IVD regulated diagnostic, a highly accurate COVID-19 test called LamPORE | Oxford Nanopore Technology | |
13 Aug 1918
Frederick Sanger, twice Nobel Prize winner, born
14 Aug 1928
Ray Wu was born in Beijing, China
3 Jun 1929
Werner Arber was born in Granichen, Switzerland
23 Jan 1930
Beverly Griffin was born in Delhi, Louisiana, USA
23 Aug 1931
Hamilton O Smith was born in New York City, USA
1932
Sanger attends Bryanston School, Dorset, as boarder
21 Mar 1932
Walter Gilbert was born in Boston MA, USA
1936 - 1940
Sanger takes degree in Natural Sciences at Cambridge University
1940 - 1943
Sanger studies for a doctorate at Cambridge University
27 Mar 1942
John E Sulston born in Cambridge, UK
1944
Sanger starts working on amino acid composition of insulin
14 Oct 1946
J Craig Venter was born in Salt Lake City, Utah
1952
First observation of the modification of viruses by bacteria
1955
Sanger completes the full sequence of amino acids in insulin
1957
Victor Ingram breaks the genetic code behind sickle-cell anaemia using Sanger's sequencing technique
1958
Sanger awarded his first Nobel Prize in Chemistry
1960
National Biomedical Research Foundation established
1960
Sanger begins to devise ways to sequence nucleic acids, starting with RNA
1962
Sanger moves to the newly created Laboratory of Molecular Biology in Cambridge
23 Jan 1962
Idea of restriction and modification enzymes born
1965
Transfer RNA is the first nucleic acid molecule to be sequenced
1965
First comprehensive protein sequence and structure computer data published as 'Atlas of Protein Sequence and Structure'
1965
Ledley publishes Uses of Computers in Biology and Medicine
1965
Sanger and colleagues publish two-dimension partition sequencing method
1 Oct 1965
Werner Arber predicted restriction enzymes could be used as a labortory tool to cleave DNA
1967
First automatic protein sequencer developed
1968
The first partial sequence of a viral DNA is reported
1969
First principles for PCR published
1969
New species of bacterium is isolated from hot spring in Yellowstone National Park by Thomas Brock
Jul 1970
First restriction enzyme isolated and characterised
1971
Process called repair replication for synthesising short DNA duplexes and single-stranded DNA by polymerases is published
May 1971
Complete sequence of bacteriophage lambda DNA reported
Dec 1971
First experiments published demonstrating the use of restriction enzymes to cut DNA
1973
The sequencing of 24 basepairs is reported
1975
Sanger and Coulson publish their plus minus method for DNA sequencing
1977
Complete sequence of bacteriophage phi X174 DNA determined
1977
First computer programme written to help with the compilation and analysis of DNA sequence data
Feb 1977
Two different DNA sequencing methods published that allow for the rapid sequencing of long stretches of DNA
Oct 1978
Nobel Prize given in recognition of discovery of restriction enzymes and their application to the problems of molecular genetics
1980
Sanger awarded his second Nobel Prize in Chemistry
Jan 1980
European Molecular Biology Laboratory convenes meeting on Computing and DNA Sequences
1980
Polyoma virus DNA sequenced
15 Sep 1980
Largest nucleic acid sequence database in the world made available free over telephone network
1982
Whole genome sequencing method is introduced for DNA sequencing
Jun 1982
NIH agrees to provide US$3.2 million over 5 years to establish and maintain a nucleic sequence database
1983
Sanger retires
1983
Polymerase chain reaction (PCR) starts to be developed as a technique to amplify DNA
Jun 1984
Results from PCR experiments start being reported
10 Sep 1984
First genetic fingerprint revealed
Mar 1985
Mullis and Cetus Corporation filed patent for the PCR technique
7 Mar 1985
DNA fingerprinting principle laid out
17 May 1985
1st legal case resolved using DNA fingerprinting
20 Dec 1985
The Polymerase Chain Reaction (PCR) technique was published
1986
First machine developed for automating DNA sequencing
1986
Plans for sequencing human genome first laid out
1988
US Congress funds genome sequencing
Apr 1988
Development of first rapid search computer programme to identify genes in a new sequence
25 May 1989
David Deamer draws the first sketch to use a biological pore to sequence DNA
25 May 1989
First pitch for US Human Genome Project
1 Oct 1990
Human Genome Project formally launched
Dec 1990
BRCA1, a single gene on chromosome 17, shown to be responsible for many breast and ovarian cancers
21 Dec 1990
BRCA1 gene linked with inherited predisposition to cancer
1992
GenBank is integrated into the NIH National Center for Biotechnology Information
1992
Genetically engineered alpha-haemolysin pore shown to have potential as a biosensor
1 Mar 1992
Method devised to isolate methylated cytosine residues in individual DNA strands providing avenue to undertake DNA methylation genomic sequencing
Dec 1992
First experiments show potential of alpha-haemolysin pore for nanopore sequencing
17 Mar 1995
First patent filed for nanopore sequencing
28 Jul 1995
First complete genome sequence published for a self-replicating free-living organism
1996
Complete genome sequence of the first eukaryotic organism, the yeast S. cerevisiae, is published
1996
Pyrosequencing is introduced for DNA sequencing
Nov 1996
First paper published highlighting the potential of nanopore sequencing
May 1998
Commercial Human Genome Project launched
11 Jun 1998
Complete genome sequence of bacteria that causes tuberculosis published
17 Jul 1998
Genome map published for Treponema pallidum, bacteria that causes syphilis
18 Aug 1998
First patent granted for nanopore sequencing (US patent 5,795,782 )
11 Dec 1998
Publication of complete genome sequence of the nematode worm Caenorhabditis elegans
1999
First human chromosome sequence published
Dec 1999
Term 'nanopore' used for first time in a publication
2000
Complete sequences of the genomes of the fruit fly Drosophila and the first plant, Arabidopsis, are published
26 Jun 2000
Human genome draft sequence announced
14 Dec 2000
First complete plant genome sequenced
Feb 2001
First consensus sequence of human genome published
Mar 2001
Paper published demonstrating possibility of using ion channel to identify individual DNA hairpin molecules
1 Jul 2001
Individual DNA strands, up to 30 nucleotides in length, identified using an engineered nanopore
2002
Complete genome sequence of the first mammalian model organism, the mouse, is published
12 Jul 2002
Polio: First ever virus synthesised from chemicals alone
3 Oct 2002
Genomic sequence of the principal malaria parasite and vector completed
Apr 2003
The sequence of the first human genome was published
23 Dec 2004
FDA approved first DNA microarray diagnostic device
2005
Oxford Nanopore Technology formally registered as a company
Dec 2005
Oxford Nanopore Technology secured two rounds of seed funding from IP Group Plc
12 Jan 2006
First time four bases of DNA shown to be easily identified using engineered alpha-haemoplysin pore with a molecular adaptor
May 2006
Last human chromosome is sequenced
Jun 2006
Oxford Nanopore Technology raises £7.7 million from various sources allowing it to expand its team
2007 - 2016
Human Microbiome Project (HMP) carried out
May 2007
Oxford Nanopore Technology decides to focus its resources on developing nanopore sequencing for DNA sequencing
2008 - 2012
METAgenomics of the Human Intestinal Tract (MetaHIT) project carried out
10 Feb 2008
Ray Wu died in Ithaca, USA
Jan 2011
DNA sequencing proves useful to documenting the rapid evolution of Streptococcus pneumococci in response to the application of vaccines
Mar 2011
Hand-held DNA sequencer (MinION) successfully used to sequence first piece of DNA
15 Feb 2012 - 18 Feb 2012
MinION presented in public for first time
Jun 2012
DNA sequencing helps identify the source of an MRSA outbreak in a neornatal intensive care unit
Dec 2012
DNA sequencing utilised for identifying neurological disease conditions different from those given in the original diagnosis
19 Nov 2013
Fred Sanger, the inventor of DNA sequencing, died at the age of 95
Apr 2014
Oxford Nanopore Technology released its palm-sized DNA sequencer to researchers through its MinION Access Programme
11 Jun 2014
Nick Loman successfully used MinION to sequence the genome of the bacterium Pseudomonas aeruginosa
Apr 2015 - Oct 2015
MinION successfully used to sequence 142 Ebola virus samples in Guinea to help combat outbreak of the disease
1 Jun 2016
Mobile laboratory equipped MinIONS used to sequence and prevent spread of Zika virus in Brazil
13 Jun 2016
Beverly Griffin died
3 Nov 2017
Research showed simple blood test can identify patients at most risk of skin cancer returning
15 Nov 2017
Rare mutation of gene called Serpine 1 discovered to protect against biological ageing process
29 Jan 2018
MinION shown to be promising tool for sequencing human genome
9 Mar 2018
John E Sulson died
12 Jul 2018
Genetic test shown to accurately predict which women benefit from chemotherapy
5 Dec 2018
Genomics England completed sequencing 100,000 whole genomes
Jan 2019
High throughput nanopore sequencing device (PromethION 48) launched to support population genomics for human sequencing or plant genomics
Mar 2019
ClearLabs launches Food Safety testing using nanopore sequencing
Oct 2019
NHS introduced new fast-track DNA test to scan for rare diseases in babies and children
Dec 2019
Oxford Nanopore Technology's sequencing technology chosen for a population genome genomics programme for the first time (Abu Dhabi Genome Programme)
Jan 2020
Nanopore sequencers begin to be used with ARCTIC protocol to decode the SARS-Cov2 to help combat COVID-19 pandemic
10 Jun 2020
Oxford Nanopore Technology launched its first IVD regulated diagnostic, a highly accurate COVID-19 test called LamPORE
Science links: Science home | Cancer immunotherapy | CRISPR-Cas9 | DNA | DNA extraction | DNA polymerase | Epigenetics | Faecal microbiota transplant | Gene therapy | Immune checkpoint inhibitors | Infectious diseases | Messenger RNA (mRNA) | Monoclonal antibodies | Nanopore sequencing | Organ-on-a-chip | p53 Gene | PCR | Phage display | Phage therapy | Plasmid | Recombinant DNA | Restriction enzymes | Stem cells | The human microbiome | Transgenic animals |
Respond to or comment on this page on our feeds on Facebook, Instagram, Mastodon or Twitter.